Purchasers Seek Covington Docs In Prograf Antitrust Row

Law360, New York (June 4, 2013, 4:45 PM EDT) -- A direct purchaser class on Tuesday pushed a Massachusetts federal court to force Covington & Burling LLP to produce evidence that could be relevant to multidistrict antitrust litigation accusing Astellas Pharma US Inc. of delaying entry of a generic form of its immunosuppressant Prograf.

A class comprising retail pharmacies and other direct purchasers of Prograf lodged a motion to compel documents from Covington, which was hired to help Astellas file an allegedly sham U.S. Food and Drug Administration citizen petition that kept generic Prograf off the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.